Volume 13 Issue 4 - April 2010
| |
Colour Key: |
| |
NICE or Department of Health guideline |
| |
SIGN guideline |
| |
Independent professional body guideline |
| |
Working party guideline |
| |
Other articles |
| |
Editorial |
| |
Management of obesity is a major health priority
|
|
| |
News |
| |
SIGN updates guideline on management of diabetes
|
|
| |
Editorial |
| |
Variability in blood pressure is a predictor of stroke
|
| |
Dr Alan Begg reviews recent analyses on the clinical impact of visit-to-visit variability of BP and the effect of different drug classes |
|
| |
Personal View |
| |
SIGN provides best practice advice on care of obesity
|
| |
Dr Matt Capehorn reiterates the importance of primary care in the prevention and management of the obesity epidemic |
|
| |
New Guideline |
| |
Suspected Parkinson’s disease should be referred untreated
|
| |
Dr Katherine Grosset, Dr Graeme Macphee, and Dr Donald Grosset review the SIGN guideline on the diagnosis and pharmacological management of Parkinson’s disease |
|
| |
Guideline Revisited |
| |
Atopic eczema can have a significant impact on patients and carers
|
| |
Management of atopic eczema in children should include assessment of psychosocial factors and avoidance of irritants and triggers, says Dr Nigel Stollery |
|
| |
Guideline Revisited |
| |
Breakthrough pain is often poorly controlled in patients with cancer
|
| |
Dr Andrew Davies discusses current pharmacological options and the benefits that novel formulations can bring in the management of breakthrough cancer pain |
|
| |
Out of Hours |
| |
Being a doctor means having difficult conversations
|
| |
Dr Phil Hammond, broadcaster and sessional GP in Bristol |
|